Safety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I Disorder

Phase 2 Completed 60 enrolled Memory Pharmaceuticals Stanley Medical Research Institute · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to establish the potential of MEM 1003 as a safe and effective treatment for patients with an acute manic or mixed episode of bipolar disorder.

Timeline

Start: 2006-09
Primary completion: 2006-12
Completion: 2007-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	MEM 1003	Small molecule	—	—

Safety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I Disorder

Summary

Timeline

Drugs

Indications